- Volume is elevated versus the 13-week average, confirming attention.
BLWV-M
TLV
Week ended 07 Aug 2026
Weekly Investor Report
Blue Wave Water Capital Ltd · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
2.04 ILA
-1.7%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -98.7% below the Trend Line and sits at 0.1% of its 52-week range. The latest completed week returned -1.7%, after a -27.4% four-week move. The latest news-sentiment score is 50/100.
Setup score
24
out of 100
Latest Close
2.04 ILA
7 Aug 2026
1W Return
-1.7%
latest completed week
4W Return
-27.4%
short-term follow-through
12W Return
-99.3%
quarterly tape
Trend Breadth
32.7%
17 of 52 weeks active
Volume Ratio
1.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.7%
Latest completed week; four-week move -27.4%.
Indicator stack
18/32
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 39.84%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -98.7% below the Trend Line and sits at 0.1% of its 52-week range. The latest completed week returned -1.7%, after a -27.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1112-week average 0.43
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.11Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -27.4% over four weeks, -99.3% over 12 weeks, and -99.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year17
Trend breadth32.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.12Latest activity-pressure read.
Pressure change23.4%Four-week change in activity pressure.
Leadership-98.98Latest relative-leadership reading.
RS change-0.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-99.3%Distance below the 52-week high.
13-week volatility28.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher8 of 269 weeks finished lower.
Best week+22.1%Week of 1 May.
Worst week-99.0%Week of 5 Jun.
Latest week-1.7%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains2
Flat weeks9
Modest losses3
Sharp losses6
Recent vol28.2%13-week weekly-return volatility.
Base vol1905.1%52-week weekly-return volatility.
Up/down split19/22Count of positive and negative weeks in the 52-week window.
Average skew1053.0% / -22.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIL Healthcare
4-week rank48 / 50
Group average-3.5%
Trend breadth4.0%
Trend4.0%active weekly trend signals
MD20.0%positive activity pressure
RS2.0%positive relative leadership
Four-week leaders
IndustryIL Drug Manufacturers - Specialty & Generic
4-week rank12 / 13
Group average-6.5%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD15.4%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape26/100
Trend, activity pressure, participation, and risk combine to a 26/100 tape read.
Indicator analysis18/100Latest 12-week confirmation: trend 2/12, activity pressure 2/12, relative leadership 0/12.
Activity pressure 0.11; No reversal markers Next-Week ExpectancyNegative 39.84%Next-week expectancy is negative with a 39.84% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 2.04 ILA | -1.7% | 156.3 ILA | 95.61 ILA | -1.12 | -98.98 | 9.0K | Off |
| 31 Jul 2026 | 2.08 ILA | -26.1% | 162.5 ILA | 95.61 ILA | -1.21 | -99.00 | 6.9K | Off |
| 24 Jul 2026 | 2.81 ILA | 0.0% | 169.1 ILA | 95.61 ILA | -1.30 | -98.71 | 0 | Off |
| 17 Jul 2026 | 2.81 ILA | 0.0% | 174.4 ILA | 95.60 ILA | -1.37 | -98.72 | 2.5K | Off |
| 10 Jul 2026 | 2.81 ILA | 0.0% | 180.8 ILA | 95.59 ILA | -1.47 | -98.72 | 0 | Off |
| 3 Jul 2026 | 2.81 ILA | 0.0% | 180.8 ILA | 95.59 ILA | -1.59 | -98.79 | 0 | Off |
| 26 Jun 2026 | 2.81 ILA | 13.5% | 187.6 ILA | 95.58 ILA | -1.70 | -98.80 | 0 | Off |
| 19 Jun 2026 | 2.48 ILA | 15.2% | 194.4 ILA | 95.58 ILA | -1.35 | -99.00 | 0 | Off |
| 12 Jun 2026 | 2.15 ILA | 0.7% | 203.2 ILA | 95.58 ILA | -0.97 | -99.19 | 1.9K | Off |
| 5 Jun 2026 | 2.13 ILA | -99.0% | 211.9 ILA | 95.58 ILA | -0.32 | -99.20 | 19 | Off |
| 29 May 2026 | 215.8 ILA | 2.7% | 220.7 ILA | 95.59 ILA | 0.37 | -23.79 | 22.2K | On |
| 22 May 2026 | 210.1 ILA | -23.3% | 213.6 ILA | 94.22 ILA | 0.62 | -25.01 | 14.2K | On |
| 15 May 2026 | 274.0 ILA | -6.3% | 215.2 ILA | 92.88 ILA | 0.64 | -2.55 | 15.6K | On |
| 8 May 2026 | 292.3 ILA | -2.6% | 214.4 ILA | 91.14 ILA | 0.63 | 0.36 | 2.4K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.